Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Evaluation of a re-engineered device for penile vibratory stimulation in men with spinal cord injury

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Parental Acceptance Rate of Testicular Tissue Cryopreservation in Danish Boys with Cryptorchidism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. COVID and CopMich: comparing and contrasting COVID-19 experiences in the USA and Scandinavia

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Quality of Information in YouTube Videos on Erectile Dysfunction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Standardized reporting for sexual function following prostate cancer treatment

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  • Emad Ibrahim
  • Christian F S Jensen
  • Ivan Sunara
  • Kajal Khodamoradi
  • Teodoro C Aballa
  • Stacy Elliott
  • Jens Sonksen
  • Dana A Ohl
  • Claes Hultling
  • Charles M Lynne
  • Stephen W J Seager
  • Nancy L Brackett
Vis graf over relationer

STUDY DESIGN: Cohort study OBJECTIVES: The purpose of this study was to evaluate the performance of a re-engineered device (Ferticare 2.0), which is replacing the previous standard (Ferticare 1.0) for penile vibratory stimulation in men with spinal cord injury. Most men with spinal cord injury are anejaculatory, requiring medical assistance to obtain their semen. Penile vibratory stimulation is generally recognized as the standard of care for semen retrieval in these anejaculatory men.

SETTING: Major Research University in Miami, Florida, USA.

METHODS: The Ferticare 2.0 device was applied to 15 men with spinal cord injury in a three-step protocol simulating normal use. Step 1: one device (2.5 mm amplitude, 100 Hz) was applied to the glans penis for 2 min. Step 2: If no ejaculation occurred, the amplitude was increased to 4.0 mm (100 Hz) and the device similarly applied. Step 3: If no ejaculation occurred, two devices, each 2.5 mm and 100 Hz were applied to the dorsum and frenulum of the glans penis. Participants at risk for autonomic dysreflexia were pretreated with sublingual nifedipine (20 mg), 15 min prior to stimulation. Blood pressure and other symptoms of autonomic dysreflexia were monitored. Participants answered a questionnaire about their experience with the device.

RESULTS: Thirteen of 15 participants ejaculated with the device. No adverse events occurred. All participants commented they would recommend the device to other men with spinal cord injury.

CONCLUSIONS: A re-engineered device, the Ferticare 2.0, is safe and effective for inducing ejaculation in men with spinal cord injury.

OriginalsprogEngelsk
TidsskriftSpinal Cord
Vol/bind59
Udgave nummer2
Sider (fra-til)151-158
Antal sider8
ISSN1362-4393
DOI
StatusUdgivet - feb. 2021

ID: 61830328